1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Mycobacterium Avium-Intracellulare Infections – Pipeline
Review, H2 2012
RSS link of Global Markets Direct
Summary
Global Markets Direct’s, Mycobacterium Avium-Intracellulare Infections - Pipeline
Review, H2 2012, provides an overview of the Mycobacterium Avium-Intracellulare
Infections therapeutic pipeline. This report provides information on the therapeutic
development for Mycobacterium Avium-Intracellulare Infections, complete with
latest updates, and special features on late-stage and discontinued projects. It also
reviews key players involved in the therapeutic development for Mycobacterium
Avium-Intracellulare Infections. Mycobacterium Avium-Intracellulare Infections -
Pipeline Review, H2 2012 is built using data and information sourced from Global
Markets Direct’s proprietary databases, Company/University websites, SEC filings,
investor presentations and featured press releases from company/university sites
and industry-specific third party sources, put together by Global Markets Direct’s
team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Mycobacterium Avium-
Intracellulare Infections.
- A review of the Mycobacterium Avium-Intracellulare Infections products under
2. development by companies and universities/research institutes based on
information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Table of contents:
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Mycobacterium Avium-Intracellulare Infections Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Mycobacterium Avium-Intracellulare
Infections 7
Mycobacterium Avium-Intracellulare Infections Therapeutics under Development
by Companies 9
Mycobacterium Avium-Intracellulare Infections Therapeutics under Investigation
by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Mycobacterium Avium-Intracellulare Infections Therapeutics – Products under
Development by Companies 14
Mycobacterium Avium-Intracellulare Infections Therapeutics – Products under
Investigation by Universities/Institutes 15
Companies Involved in Mycobacterium Avium-Intracellulare Infections
Therapeutics Development 16
Mycobacterium Avium-Intracellulare Infections – Therapeutics Assessment 16
Assessment by Monotherapy Products 16
Assessment by Combination Products 17
3. Assessment by Route of Administration 18
Assessment by Molecule Type 20
Drug Profiles 22
Clarithromycin + Ethambutol + Rifabutin - Drug Profile 22
Product Description 22
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1
Mycobacterium Avium-Intracellulare Infections – Pipeline Review, H2 2012
Clostridium Infections – Pipeline Review, H2 2012
AIDS - Related Lymphoma – Pipeline Review, H2 2012
Angina (Angina Pectoris) – Pipeline Review, H2 2012
Urinary Tract Cancer – Pipeline Review, H2 2012
Anaplastic Astrocytoma – Pipeline Review, H2 2012
Penile Cancer – Pipeline Review, H2 2012
4. Natural Killer Cell Lymphomas – Pipeline Review, H2 2012
Medullary Thyroid Cancer – Pipeline Review, H2 2012
Fever – Pipeline Review, H2 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com